FULC
Fulcrum Therapeutics Inc
NASDAQ: FULC · HEALTHCARE · BIOTECHNOLOGY
$7.15
-3.90% today
Updated 2026-04-29
Market cap
$522.15M
P/E ratio
—
P/S ratio
2.66x
EPS (TTM)
$-1.18
Dividend yield
—
52W range
$4 – $16
Volume
1.2M
Fulcrum Therapeutics Inc (FULC) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-20.07M | $-22.56M | $-39.48M | $-53.66M | $-78.48M | $-97.05M | $-90.97M | $-2.22M | $-60.06M |
| Capital expenditures | $1.91M | $8.98M | $853000.00 | $1.34M | $1.71M | $1.96M | $508000.00 | $278000.00 | $314000.00 |
| Depreciation | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $1.37M | $2.16M | $4.22M | $7.35M | $11.07M | $13.35M | $14.80M | $14.55M | $12.47M |
| Free cash flow | $-21.98M | $-31.54M | $-40.34M | $-55.00M | $-80.19M | $-99.01M | $-91.47M | $-2.50M | $-60.38M |
| Investing cash flow | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — |
| Dividends paid | $0.00 | $0.00 | — | $68.52M | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — |
| Net change in cash | $0.00 | $0.00 | — | $-39.66M | $-21.64M | $-314000.00 | — | — | — |